Efficacy of a new ready-to-use vaccine against PCV-2d and Mycoplasma hyopneumoniae under experimental conditions by R Krejci, P Trampus, A Csagola, T Szalai, N Palmai, A Toth, N Terenyi, Z Nagy, NA Szeplaki, G Somogyi, T Barna, E Rausch, Z Penzes, M Szaszko, Z Lorincz

Get full text